INVO Bioscience, Inc. (INVO)

INVO Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	0.23	0.09	5.68	10.1	1.24
Cash & Cash Equivalents	0.23	0.09	5.68	10.1	1.24
Cash Growth	157.86%	-98.41%	-43.70%	715.27%	483.57%
Receivables	0.14	0.08	0.05	0.02	0.01
Inventory	0.26	0.26	0.29	0.27	0.1
Other Current Assets	0.62	0.19	0.28	0.16	0.2
Total Current Assets	1.26	0.62	6.31	10.54	1.54
Property, Plant & Equipment	6.57	2.24	2.54	0.21	0.19
Long-Term Investments	3.09	1.24	1.49	0.1	0
Goodwill and Intangibles	9.97	0	0.13	0.09	0.06
Other Long-Term Assets	0	0	0	0	0
Total Long-Term Assets	19.63	3.48	4.16	0.4	0.25
Total Assets	20.89	4.1	10.47	10.95	1.8
Accounts Payable	2.33	1.35	0.44	0.33	0.37
Deferred Revenue	0.41	0.12	0.01	3.57	4.29
Current Debt	1.51	0.76	0	0.69	0.02
Other Current Liabilities	3.97	1.18	0.8	-2.31	-3.18
Total Current Liabilities	8.22	3.41	1.25	2.29	1.5
Long-Term Debt	6.78	1.67	1.9	0.06	0.44
Other Long-Term Liabilities	5	0	0	2.86	3.57
Total Long-Term Liabilities	11.78	1.67	1.9	2.92	4.01
Total Liabilities	19.99	5.08	3.16	5.2	5.51
Total Debt	8.29	2.43	1.9	0.75	0.46
Debt Growth	240.62%	27.93%	152.76%	64.45%	15.64%
Retained Earnings	-57.82	-49.78	-38.89	-32.24	-23.89
Shareholders' Equity	0.89	-0.98	7.31	5.74	-3.71
Net Cash / Debt	-8.05	-2.34	3.78	9.35	0.78
Net Cash / Debt Growth	-	-	-59.52%	1096.42%	-
Net Cash Per Share	-5.14	-3.86	7.12	34.05	3.22
Working Capital	-6.96	-2.79	5.05	8.25	0.04
Book Value Per Share	0.57	-1.61	13.75	20.92	-15.30

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).